Pfizer Overview

  • Founded
  • 1849
Founded
  • Status
  • Public
  • Employees
  • 88,300
Employees
  • Stock Symbol
  • PFE
Stock Symbol
  • Investments
  • 99
  • Share Price
  • $38.31
  • (As of Monday Closing)

Pfizer General Information

Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Biotechnology
Stock Exchange
NYS
Primary Office
  • 235 East 42nd Street
  • New York, NY 10017
  • United States
+1 (212) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pfizer Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$38.31 $37.23 $26.41 - $39.78 $207B 5.56B 34.3M $1.56

Pfizer Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 256,396,489 260,711,914 283,866,715 243,284,819
Revenue 48,649,000 51,750,000 53,647,000 52,546,000
EBITDA 15,104,000 25,040,000 19,252,000 19,453,000
Net Income 8,686,000 16,273,000 11,153,000 21,308,000
Total Assets 178,983,000 167,489,000 159,422,000 171,797,000
Total Debt 61,528,000 52,150,000 41,740,000 43,492,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pfizer Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pfizer‘s full profile, request access.

Request a free trial

Pfizer Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a
Pharmaceuticals
New York, NY
88,300 As of 2019
000000 - 000

00000000

rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
000000000000000
Brentford, United Kingdom
00000 As of 0000
00000000000

00000000

it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
000000000000000
Basel, Switzerland
000000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pfizer Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlaxoSmithKline Corporation Brentford, United Kingdom 00000 00000000000
00000000 Corporation Basel, Switzerland 000000 000000000000
00000000000 Formerly PE-Backed Cambridge, United Kingdom 00000 000 00000000 000
0000000 & 0000000 Corporation New Brunswick, NJ 000000 0000
000000 00000000000 Corporation Tokyo, Japan 00000 00000000
You’re viewing 5 of 18 competitors. Get the full list »

Pfizer Executive Team (322)

Name Title Board Seat Contact Info
Albert Bourla Ph.D Chief Executive Officer & Chairman
Mikael Dolsten Ph.D Chief Scientific Officer & President, Worldwide Research, Development and Medical
John Young Chief Business Officer & Group President
Mike Gladstone Global President of Internal Medicine for Pfizer Innovative Health
Angela Hwang President, Divisional
You’re viewing 5 of 322 executive team members. Get the full list »

Pfizer Board Members (24)

Name Representing Role Since
000000 000000 00.0 Pfizer Chief Executive Officer & Chairman 000 0000
000 0000000 00.0 Pfizer Board Member 000 0000
00000 0000000 Pfizer Director, Portfolio Director & Planning Lead, PMP, Pfizer Oncology 000 0000
000 00000000 Self Board Member 000 0000
00000 00000 Pfizer Board Member 000 0000
You’re viewing 5 of 24 board members. Get the full list »

Pfizer Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pfizer Investments & Acquisitions (99)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 16-Nov-2020 000000000000000000 0000 Pharmaceuticals 000000 000000 00.0
0000000 29-Oct-2020 00000 00000 00 00000 Biotechnology
0000000 0000000000 27-Oct-2020 0000 00000 Drug Discovery 0000000 00000000
00000 000000000000 22-Oct-2020 000000000000000000 Drug Discovery 000000000 00000000
CStone Pharmaceuticals 30-Sep-2020 PIPE 00000 Biotechnology
You’re viewing 5 of 99 investments and acquisitions. Get the full list »

Pfizer Subsidiaries (21)

Company Name Industry Location Founded
Arixa Pharmaceuticals Drug Discovery Palo Alto, CA 2016
000000 00000000000 Biotechnology Chapel Hill, NC 0000
0000000000 Pharmaceuticals Piscataway Township, NJ 0000
0000000 000(0) 000 Corporate Pension Peapack, NJ 0000
0000000 Medical Supplies Lake Forest, IL 0000
You’re viewing 5 of 21 subsidiaries. Get the full list »

Pfizer Exits (25)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 04-Jan-2019 000000000 00000 Completed
  • 2 buyers
0000000 0000000000 01-Nov-2017 000000000 00000 Completed
  • 000000
00 000000 00000000 13-Dec-2016 000000000 Completed
  • 000000
00000000 000000000 04-Aug-2016 000 0000 Completed
  • 5 buyers
Gemphire Therapeutics 09-Mar-2016 Early Stage VC 000.00 Completed
  • 12 buyers
You’re viewing 5 of 25 exits. Get the full list »